{
  "id": "5cc0817da49efeb44c000002",
  "type": "summary",
  "question": "What is circulating free DNA ( cfDNA)?",
  "ideal_answer": "Known to be present in the blood of cancer patients for decades, cell-free DNA (cfDNA) is beginning to inform on tumor genetics, tumor burden, and mechanisms of progression and drug resistance.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/26697469",
    "http://www.ncbi.nlm.nih.gov/pubmed/27422709",
    "http://www.ncbi.nlm.nih.gov/pubmed/25896555",
    "http://www.ncbi.nlm.nih.gov/pubmed/29175734",
    "http://www.ncbi.nlm.nih.gov/pubmed/23674341",
    "http://www.ncbi.nlm.nih.gov/pubmed/29314147"
  ],
  "snippets": [
    {
      "text": "Cell-free DNA (cfDNA) and cell-free RNA (cfRNA), RNA associated to platelets and circulating tumor cells (CTCs) are some of the materials that can be derived from the blood of cancer patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26697469",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Known to be present in the blood of cancer patients for decades, cell-free DNA (cfDNA) is beginning to inform on tumor genetics, tumor burden, and mechanisms of progression and drug resistance. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27422709",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This study aimed to determine the principal factors contributing to the cost of avoiding a birth with Down syndrome by using cell-free DNA (cfDNA) to replace conventional screening.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23674341",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "cfDNA was isolated from a serum specimen before chemotherapy. Its value was correlated to recurrence-free and overall survival using Kaplan-Meier curves. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25896555",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Cell-free fetal DNA analysis for non-invasive prenatal screening of fetal chromosomal aneuploidy has been widely adopted for clinical use. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29314147",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}